Marker Therapeutics, Inc. (MRKR)
NASDAQ: MRKR · Real-Time Price · USD
1.460
+0.070 (5.04%)
Apr 8, 2026, 4:00 PM EDT - Market closed
Marker Therapeutics Market Cap
Marker Therapeutics has a market cap or net worth of $24.34 million as of April 8, 2026. Its market cap has increased by 117.35% in one year.
Market Cap
24.34M
Enterprise Value
8.27M
1-Year Change
117.35%
Ranking
Category
Stock Price
$1.46
Market Cap Chart
Since November 8, 2016, Marker Therapeutics's market cap has decreased from $45.80M to $24.34M, a decrease of -46.85%. That is a compound annual growth rate of -6.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 7, 2026 | 23.20M | -6.45% |
| Dec 31, 2025 | 24.80M | -10.79% |
| Dec 31, 2024 | 27.80M | -43.15% |
| Dec 29, 2023 | 48.90M | 120.27% |
| Dec 30, 2022 | 22.20M | -71.86% |
| Dec 31, 2021 | 78.90M | 13.36% |
| Dec 31, 2020 | 69.60M | -47.15% |
| Dec 31, 2019 | 131.70M | -47.70% |
| Dec 31, 2018 | 251.80M | 509.69% |
| Dec 29, 2017 | 41.30M | 27.08% |
| Dec 30, 2016 | 32.50M | -29.04% |
| Nov 8, 2016 | 45.80M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neuphoria Therapeutics | 24.80M |
| Lexaria Bioscience | 24.64M |
| Exicure | 24.48M |
| AEON Biopharma | 23.72M |
| Skye Bioscience | 23.57M |
| NanoViricides | 23.32M |
| Tempest Therapeutics | 22.38M |
| Outlook Therapeutics | 22.28M |